Search results for: Septin 5 Antibodies, WB control
#37550073 
2023/08/07
To Up
Utility of Protein Microarrays for Detection of Classified and Novel Antibodies in Autoimmune Neurologic Disease.
Neural antibodies are detected by tissue-based indirect immunofluorescence assay (IFA) in Mayo Clinic's Neuroimmunology Laboratory practice, but the process of characterizing and validating novel antibodies is lengthy. We report our assessment of human protein arrays.Andrew McKeon, Connie Lesnick, Nisa Vorasoot, Monica W Buckley, Surendra Dasari, Eoin P Flanagan, Michael Gilligan, Reghann Lafrance-Corey, Ramona Miske, Sean J Pittock, Madeleine Scharf, Binxia Yang, Anastasia Zekeridou, Divyanshu Dubey, John Mills
1125 related Products with: Utility of Protein Microarrays for Detection of Classified and Novel Antibodies in Autoimmune Neurologic Disease.
100 μg100 100.00 ug100 units1 mg100 100.00 ug200 100 μg2 Pieces/Box100 μg100 μg
Related Pathways
#36845122 2023/02/08
To Up
Autoantibody profiles in patients with immune checkpoint inhibitor-induced neurological immune related adverse events.
Neurological immune-related adverse events (irAE-n) are severe and potentially fatal toxicities of immune checkpoint inhibitors (ICI). To date, the clinical significance of neuronal autoantibodies in irAE-n is poorly understood. Here, we characterize neuronal autoantibody profiles in patients with irAE-n and compare these with ICI-treated cancer patients without irAE-n.Leonie Müller-Jensen, Samuel Knauss, Lorena Ginesta Roque, Christian Schinke, Smilla K Maierhof, Frederik Bartels, Carsten Finke, Kristin Rentzsch, Claas Ulrich, Raphael Mohr, Werner Stenzel, Matthias Endres, Wolfgang Boehmerle, Petra Huehnchen